Clinical Trial Update: APG-115 in Salivary Gland Cancer Trial [Phase 1, Phase 2]

View source ↗

Summary

This is an update on a Phase 1/2 trial of APG-115 for salivary gland cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Gland Cancer

Drugs mentioned

• APG-115 (APG-115)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Malignant Salivary Gland Cancer, Salivary Gland Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING